arrow
S

Shantan Venishetty

aig hospitals
H指数:8
被引数:235

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prior Decompensation Shapes the Clinical Phenotype and the Prognostic Performance of Biochemical Liver-Failure Criteria in Hospitalised Cirrhosis patients: A Multicentre Study

既往失代偿情况塑造了住院肝硬化患者生化肝衰竭标准的临床表型及预后表现:一项多中心研究

2026-10-160
PRE
Effectiveness and safety of thalidomide for gastric antral vascular ectasia (GAVE) related recurrent gastrointestinal bleed in liver cirrhosis: A Prospective Observational Study

硫唑嘌呤对肝硬化相关胃窦血管发育不良(GAVE)所致反复消化道出血的有效性与安全性:一项前瞻性观察研究

2026-10-130
PRE
Outcomes after technically successful transjugular intrahepatic portosystemic shunt for conventional indications and high-risk clinical subgroups: a multicenter cohort study

经颈静脉肝内门体分流术技术成功后,常规适应证和高风险临床亚组的结局:一项多中心队列研究

2026-09-290
OAAI
Acute-on-chronic liver failure (ACLF): the 'Kyoto Consensus'-steps from Asia

急慢性肝衰竭(ACLF):来自亚洲的“京都共识”进展

2025-02-170
OAAI
Antibiotics With or Without Rifaximin for Acute Hepatic Encephalopathy in Critically Ill Patients With Cirrhosis: A Double-Blind, Randomized Controlled (ARiE) Trial
2023-11-096
PRE